These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32405281)

  • 1. Sars-CoV-2 and black population: ACE2 as shield or blade?
    Vinciguerra M; Greco E
    Infect Genet Evol; 2020 Oct; 84():104361. PubMed ID: 32405281
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.
    Gupta R; Charron J; Stenger CL; Painter J; Steward H; Cook TW; Faber W; Frisch A; Lind E; Bauss J; Li X; Sirpilla O; Soehnlen X; Underwood A; Hinds D; Morris M; Lamb N; Carcillo JA; Bupp C; Uhal BD; Rajasekaran S; Prokop JW
    J Biol Chem; 2020 Aug; 295(33):11742-11753. PubMed ID: 32587094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.
    Su S; Jiang S
    Signal Transduct Target Ther; 2020 May; 5(1):71. PubMed ID: 32435059
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients.
    Novelli A; Biancolella M; Borgiani P; Cocciadiferro D; Colona VL; D'Apice MR; Rogliani P; Zaffina S; Leonardis F; Campana A; Raponi M; Andreoni M; Grelli S; Novelli G
    Hum Genomics; 2020 Sep; 14(1):29. PubMed ID: 32917283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype.
    Camiolo M; Gauthier M; Kaminski N; Ray A; Wenzel SE
    J Allergy Clin Immunol; 2020 Aug; 146(2):315-324.e7. PubMed ID: 32531372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
    Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
    Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.
    Milne S; Yang CX; Timens W; Bossé Y; Sin DD
    Lancet Respir Med; 2020 Jun; 8(6):e50-e51. PubMed ID: 32411576
    [No Abstract]   [Full Text] [Related]  

  • 8. [ACE2 and coronavirus - a question of balance and dynamics?].
    Lundström A; Sandén P
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic and epigenetic variability, and the Covid-19 pandemic].
    Rivera-Silva G
    Salud Publica Mex; 2020; 62(5):462-463. PubMed ID: 32668509
    [No Abstract]   [Full Text] [Related]  

  • 10. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation.
    Alshahawey M; Raslan M; Sabri N
    Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.
    Tan HW; Xu YM; Lau ATY
    Rev Med Virol; 2020 Sep; 30(5):e2122. PubMed ID: 32602627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2.
    Young MJ; Clyne CD; Chapman KE
    J Endocrinol; 2020 Nov; 247(2):R45-R62. PubMed ID: 32966970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are children less susceptible to COVID-19?
    Lee PI; Hu YL; Chen PY; Huang YC; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):371-372. PubMed ID: 32147409
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.
    Tan CS; Yeoh SF; Long CM
    Ann Acad Med Singap; 2020 Jun; 49(6):398-400. PubMed ID: 32712639
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates.
    Alazmi M; Motwalli O
    J Mol Model; 2020 Nov; 26(12):338. PubMed ID: 33175236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs.
    Ciulla MM
    Hypertens Res; 2020 Sep; 43(9):985-986. PubMed ID: 32523133
    [No Abstract]   [Full Text] [Related]  

  • 17. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.
    Hou Y; Zhao J; Martin W; Kallianpur A; Chung MK; Jehi L; Sharifi N; Erzurum S; Eng C; Cheng F
    BMC Med; 2020 Jul; 18(1):216. PubMed ID: 32664879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 challenging cell biology.
    Bullerdiek J
    Protoplasma; 2020 May; 257(3):619-620. PubMed ID: 32333127
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.
    Murray E; Tomaszewski M; Guzik TJ
    Cardiovasc Res; 2020 Jun; 116(7):e87-e89. PubMed ID: 32301968
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated.
    Wambier CG; Goren A
    J Am Acad Dermatol; 2020 Jul; 83(1):308-309. PubMed ID: 32283245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.